180 Life Sciences
ATNF7.0400.00% ( 0.000 )
Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: 180 Life Sciences(ATNF) the EBIT is -1.73 M (+6.3%);the EPS is -0.302 (-3125%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B6.30%
----
----
EPS
-0.30253125.11%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf